Edition:
United States

LeMaitre Vascular Inc (LMAT.OQ)

LMAT.OQ on NASDAQ Stock Exchange Global Market

23.26USD
23 Jan 2017
Change (% chg)

-- (--)
Prev Close
$23.26
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
43,220
52-wk High
$26.88
52-wk Low
$12.03

LMAT.OQ

Chart for LMAT.OQ

About

LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company and its subsidiaries develop, manufacture and market medical devices and implants used primarily in the field of vascular surgery. It operates in the design, marketing, sales and technical support of medical... (more)

Overall

Beta: 0.65
Market Cap(Mil.): $433.75
Shares Outstanding(Mil.): 18.58
Dividend: 0.05
Yield (%): 0.77

Financials

  LMAT.OQ Industry Sector
P/E (TTM): 42.47 33.72 30.38
EPS (TTM): 0.55 -- --
ROI: 12.60 13.18 14.86
ROE: 13.08 16.79 16.28

BRIEF-Lemaitre Vascular acquires Restore Flow Allografts

* Lemaitre Vascular Inc- expects acquisition to increase Q4 and full-year 2016 revenues by $550,000 and to reduce Q4 and full-year 2016 operating income by $200,000

Nov 10 2016

BRIEF-Lemaitre Vascular Q3 EPS $0.17

* Q3 earnings per share view $0.15 -- Thomson Reuters I/B/E/S

Oct 26 2016

BRIEF-Lemaitre Vascular says Q2 earnings per share $0.14

* Lemaitre q2 2016 record sales $22.4mm (+13%), record op. Income $3.8mm (+35%)

Jul 27 2016

Competitors

  Price Chg
Terumo Corp (4543.T) ¥4,155 -15.00
Getinge AB (GETIb.ST) 152.50kr -0.20
C R Bard Inc (BCR.N) $231.29 -0.17
Edwards Lifesciences Corp (EW.N) $95.00 -0.51
Cardiovascular Systems Inc (CSII.OQ) $24.95 --

Earnings vs. Estimates